The Bioprosthetics Market was valued at USD 5.91 billion in 2024, and is projected to reach USD 7.64 billion by 2030, rising at a CAGR of 4.40%. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.
Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.
The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.
This product will be delivered within 1-3 business days.
Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.
The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.
Bioprosthetics Market Report Highlights
- The allograft product segment dominated the market and accounted for a share of 69.6% in 2024, owing to the increasing geriatric population and advancement in allograft procedures.
- By application, the plastic surgery and wound healing segment is expected to witness significant CAGR growth over the forecast period, owing to rising demand for minimally invasive surgery and technological advancement.
- Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments.
- The North American bioprosthetics market held a dominant position with a revenue share of 37.1% in 2024, owing to the increasing prevalence of cardiovascular diseases and developed healthcare infrastructure.
- For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe.
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Endoscopic Submucosal Dissection Market Variables, Trends & Scope
Chapter 4. Bioprosthetics Market Segment Analysis, by Product, 2018-2030 (USD Million)
Chapter 5. Bioprosthetics Market Segment Analysis, by Application, 2018-2030 (USD Million)
Chapter 6. Bioprosthetics Market Segment Analysis, by Region, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Bioprosthetics market report include:- LeMaitre Vascular, Inc.
- Braile Biomédica
- Labcor Laboratories Ltda.
- Medtronic
- Rua Life Sciences Plc (Aortech International Plc.)
- LivaNova PLC (Sorin Group)
- Organogenesis Inc.
- Humacyte Global, Inc.
- Johnson & Johnson (Ethicon, Inc.)
- Artivion, Inc. (CryoLife, Inc.)
- Abbott (St. Jude Medical, Inc.)
- Edwards Lifesciences Corporation.
- JenaValve
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | February 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 5.91 Billion |
Forecasted Market Value ( USD | $ 7.64 Billion |
Compound Annual Growth Rate | 4.4% |
Regions Covered | Global |
No. of Companies Mentioned | 14 |